» Articles » PMID: 29483846

Integrated TCGA Analysis Implicates LncRNA CTB-193M12.5 As a Prognostic Factor in Lung Adenocarcinoma

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2018 Feb 28
PMID 29483846
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Lung cancer is a malignant tumor with the highest incidence and mortality around the world. Recent advances in RNA sequencing technology have enabled insights into long non-coding RNAs (lncRNAs), a previously largely overlooked species in dissecting lung cancer pathology.

Methods: In this study, we used a comprehensive bioinformatics analysis strategy to identify lncRNAs closely associated with lung adenocarcinoma, using the RNA sequencing datasets collected from more than 500 lung adenocarcinoma patients and deposited at The Cancer Genome Atlas (TCGA) database.

Results: Differential expression analysis highlighted lncRNAs CTD-2510F5.4 and CTB-193M12.5, both of which were significantly upregulated in cancerous specimens. Moreover, network analyses showed highly correlated expression levels of both lncRNAs with those of differentially expressed protein-coding genes, and suggested central regulatory roles of both lncRNAs in the gene co-expression network. Importantly, expression of CTB-193M12.5 showed strong negative correlation with patient survival.

Conclusions: Our study mined existing TCGA datasets for novel factors associated with lung adenocarcinoma, and identified a largely unknown lncRNA as a potential prognostic factor. Further investigation is warranted to characterize the roles and significance of CTB-193M12.5 in lung adenocarcinoma biology.

Citing Articles

The regulatory mechanism of m6A modification in gastric cancer.

Wu S, Li C, Zhou H, Yang Y, Liang N, Fu Y Discov Oncol. 2024; 15(1):283.

PMID: 39009956 PMC: 11250764. DOI: 10.1007/s12672-024-00994-2.


Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis.

Lu S, Liu X, Wu C, Zhang J, Stalin A, Huang Z Medicine (Baltimore). 2023; 102(29):e33990.

PMID: 37478241 PMC: 10662904. DOI: 10.1097/MD.0000000000033990.


Integration of lncRNAs, Protein-Coding Genes and Pathology Images for Detecting Metastatic Melanoma.

Liu S, Fan Y, Li K, Zhang H, Wang X, Ju R Genes (Basel). 2022; 13(10).

PMID: 36292801 PMC: 9602061. DOI: 10.3390/genes13101916.


Characterization of glucose metabolism in breast cancer to guide clinical therapy.

Mei Y, Zhao L, Jiang M, Yang F, Zhang X, Jia Y Front Surg. 2022; 9:973410.

PMID: 36277284 PMC: 9580338. DOI: 10.3389/fsurg.2022.973410.


Identification of a apoptosis-related LncRNA signature to improve prognosis prediction and immunotherapy response in lung adenocarcinoma patients.

Luo T, Yu S, Ouyang J, Zeng F, Gao L, Huang S Front Genet. 2022; 13:946939.

PMID: 36171881 PMC: 9510691. DOI: 10.3389/fgene.2022.946939.


References
1.
Freitas A, Gurgel A, de Lima E, Sao Marcos B, do Amaral C . Human papillomavirus and lung cancinogenesis: an overview. J Cancer Res Clin Oncol. 2016; 142(12):2415-2427. DOI: 10.1007/s00432-016-2197-1. View

2.
Chen J, Wang R, Zhang K, Chen L . Long non-coding RNAs in non-small cell lung cancer as biomarkers and therapeutic targets. J Cell Mol Med. 2014; 18(12):2425-36. PMC: 4302648. DOI: 10.1111/jcmm.12431. View

3.
Li J, Sun C, Li W, Chao R, Huang C, Zhou X . Cancer RNA-Seq Nexus: a database of phenotype-specific transcriptome profiling in cancer cells. Nucleic Acids Res. 2015; 44(D1):D944-51. PMC: 4702907. DOI: 10.1093/nar/gkv1282. View

4.
Sakai Y, Ohbayashi C, Yanagita E, Jimbo N, Kajimoto K, Sakuma T . PRR11 immunoreactivity is a weak prognostic factor in non-mucinous invasive adenocarcinoma of the lung. Pathologica. 2017; 109(3):133-139. View

5.
Bohmdorfer G, Wierzbicki A . Control of Chromatin Structure by Long Noncoding RNA. Trends Cell Biol. 2015; 25(10):623-632. PMC: 4584417. DOI: 10.1016/j.tcb.2015.07.002. View